Planning a clinical trial programme for direct-acting antivirals for chronic viral hepatitis C

Scientific relevance. Direct-acting antivirals have significantly improved the effectiveness of treatment for hepatitis C. However, Russia and the Eurasian Economic Union lack recommendations for the clinical development of medicinal products from this pharmacotherapeutic group.Aim. The study aimed...

Full description

Bibliographic Details
Main Authors: A. I. Gubenko, D. V. Goryachev, A. I. Muravieva, G. V. Shukshina
Format: Article
Language:Russian
Published: NEICON ISP LLC 2023-12-01
Series:Ведомости Научного центра экспертизы средств медицинского применения
Subjects:
Online Access:https://www.vedomostincesmp.ru/jour/article/view/499